Align Technology Inc (ALGN)
271.50
-2.06
(-0.75%)
USD |
NASDAQ |
May 17, 16:00
271.43
-0.07
(-0.03%)
After-Hours: 20:00
Align Technology Research and Development Expense (Quarterly): 91.86M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 91.86M |
December 31, 2023 | 82.16M |
September 30, 2023 | 88.74M |
June 30, 2023 | 88.48M |
March 31, 2023 | 87.45M |
December 31, 2022 | 83.52M |
September 30, 2022 | 76.97M |
June 30, 2022 | 72.96M |
March 31, 2022 | 71.81M |
December 31, 2021 | 72.48M |
September 30, 2021 | 65.59M |
June 30, 2021 | 57.72M |
March 31, 2021 | 54.54M |
December 31, 2020 | 48.89M |
September 30, 2020 | 44.53M |
June 30, 2020 | 40.36M |
March 31, 2020 | 41.53M |
December 31, 2019 | 41.33M |
September 30, 2019 | 39.68M |
June 30, 2019 | 38.85M |
March 31, 2019 | 37.50M |
December 31, 2018 | 35.80M |
September 30, 2018 | 32.70M |
June 30, 2018 | 30.80M |
March 31, 2018 | 29.59M |
Date | Value |
---|---|
December 31, 2017 | 26.17M |
September 30, 2017 | 24.20M |
June 30, 2017 | 24.38M |
March 31, 2017 | 22.80M |
December 31, 2016 | 21.61M |
September 30, 2016 | 20.42M |
June 30, 2016 | 18.61M |
March 31, 2016 | 15.08M |
December 31, 2015 | 13.89M |
September 30, 2015 | 17.78M |
June 30, 2015 | 15.68M |
March 31, 2015 | 13.88M |
December 31, 2014 | 13.28M |
September 30, 2014 | 12.85M |
June 30, 2014 | 13.29M |
March 31, 2014 | 13.38M |
December 31, 2013 | 10.97M |
September 30, 2013 | 10.92M |
June 30, 2013 | 10.92M |
March 31, 2013 | 11.28M |
December 31, 2012 | 11.71M |
September 30, 2012 | 9.952M |
June 30, 2012 | 10.68M |
March 31, 2012 | 10.53M |
December 31, 2011 | 9.568M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
38.85M
Minimum
Jun 2019
91.86M
Maximum
Mar 2024
64.47M
Average
68.70M
Median
Research and Development Expense (Quarterly) Benchmarks
Boston Scientific Corp | 366.00M |
ResMed Inc | 77.07M |
Edwards Lifesciences Corp | 285.20M |
Stryker Corp | 368.00M |
Zimmer Biomet Holdings Inc | 107.90M |